DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Sandborn WJ, Feagan BG, Marano C. et al.
Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.

Gastroenterology 2014;
146: 96-109 e1

Sandborn WJ, Feagan BG, Marano C. et al.
Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.

Gastroenterology 2014;
146: 96-109 e1

Download Bibliographical Data

Search in:
Access: